1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,321 | 0,421 | 11:33 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Theraclion Announces Major Advances and Reports First-Half Financial Results | 201 | Business Wire | On the strength of its progress on its 2023 and 2024 priorities (access to the US market, R&D and China), Theraclion is planning its commercial ramp-up for 2025 and 2026. Pivotal study for... ► Artikel lesen | |
| 06.09. | Theraclion Confirms Strong Mid-Year Achievements | 303 | Business Wire | Main focus: Access to the U.S. market, R&D and China. Key achievements in H1 2024: FDA pivotal study: treatments completed in June on schedule
Promising R&D progress in product features... ► Artikel lesen | |
| 24.06. | SONOVEIN FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule | 469 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy... ► Artikel lesen | |
| 06.06. | Theraclion: SONOVEIN Highlighted in Top Medical Conferences and Scientific Journal | 479 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 27.03. | Theraclion Announces 2023 Financial Results and Continues Its Roadmap | 321 | Business Wire | Continuation of the strategy focused on access to the US and Chinese markets for SONOVEIN®, and its improvement through R&D;
Rapid start-up of the pivotal study in the United States: two-thirds... ► Artikel lesen | |
| 29.01. | Theraclion Pursues Its Strategy and Announces Its 2023 Revenue | 564 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive focused ultrasound therapy (HIFU),... ► Artikel lesen | |
| 14.12.23 | Theraclion Delivers Its 2023 Strategic Objectives | 414 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, is now taking stock of its achievements... ► Artikel lesen |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 78,60 | +1,42 % | Aurubis, BMW, Gerresheimer, SGL Carbon, ThyssenKrupp, Zalando u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| INMODE | 16,005 | +0,38 % | InMode Ltd.: InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the ... | YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| MCKESSON | 487,30 | +0,27 % | McKesson Aktie: Ausgezeichnete Quartalszahlen! | ||
| HCA HEALTHCARE | 330,60 | +0,33 % | HCA Healthcare, Inc. - 10-Q, Quarterly Report | ||
| LIMES SCHLOSSKLINIKEN | 356,00 | 0,00 % | EQS-Adhoc: Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024 | EQS-Ad-hoc: Limes Schlosskliniken AG / Schlagwort(e): Halbjahresbericht/Vorläufiges Ergebnis
Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024
18.07.2024 / 10:17 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BEYOND AIR | 0,490 | +8,41 % | Beyond Air Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update | Appointed industry veteran, David Webster, as new Chief Commercial Officer Recently upgraded LungFit PH device expands customer base; revenue growth expected to accelerateeach quarter going forward... ► Artikel lesen | |
| CLEARDAY | - | - | Clearday, Inc.: Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing | San Antonio, Texas, July 22, 2024 (GLOBE NEWSWIRE) -- Clearday (CLRD:OTC EXMKT) ("Clearday" or the "Company") is pleased to inform market participants, partners and stakeholders of the Company's efforts... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 2,060 | -4,63 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq | PARSIPPANY, NJ, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX: IDXG) today announced that its Series B Preferred Stock investors, Ampersand Capital... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 10,200 | -0,97 % | HCSG Reports Q3 2024 Results | BENSALEM, Pa.--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2024.
Ted Wahl, Chief Executive Officer, stated, "We're... ► Artikel lesen | |
| SIENNA SENIOR LIVING | 11,500 | 0,00 % | Dividendenbekanntmachungen (31.10.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1105 EUR AGREE REALTY CORPORATION US0084921008 0,253 USD 0,233 EUR ALLIANT ENERGY... ► Artikel lesen | |
| ADDUS HOMECARE | 112,00 | 0,00 % | Addus HomeCare Announces Second Quarter 2024 Financial Results | FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the second quarter and six months ended June... ► Artikel lesen | |
| IVF HARTMANN | 149,27 | 0,00 % | IVF Hartmann im ersten Halbjahr mit mehr Gewinn | Neuhausen - Der Medizinalbedarfhersteller IVF Hartmann hat im ersten Halbjahr 2024 mehr Umsatz erzielt und deutlich mehr verdient. Im Gesamtjahr will der Konzern weiter zulegen. Der Umsatz stieg im... ► Artikel lesen | |
| ICU MEDICAL | 156,00 | -1,89 % | Smiths Group Sells 1.2 Mln Shares In ICU Medical | LONDON (dpa-AFX) - Smiths Group Plc (SMIN.L), an engineering firm, confirmed on Wednesday that it has sold 1.2 million shares in ICU Medical Inc. or around 4.9 percent of ICU's share capital.... ► Artikel lesen | |
| MODERN DENTAL | 0,432 | -3,14 % | EQS Newswire: Modern Dental Group Limited: Modern Dental Group Shared the Technological Innovation in Dentistry Along the Development of New Quality Productive Forces in CCB International Forum | EQS Newswire / 30/09/2024 / 15:43 UTC+8
Modern Dental Group Shared the Technological Innovation in Dentistry Along the Development of New Quality Productive Forces in CCB International Forum
... ► Artikel lesen | |
| FRESENIUS | 33,940 | +1,25 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 40,10 Euro auf "Overweight" belassen. Analyst David Adlington sah sich am Montagabend im Vergleich... ► Artikel lesen |
Das Unternehmen THERACLION kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,85 % bei einem Aktienkurs von 0,361 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION finden Sie auf Wallstreet Online.
